SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,995 | +33222.2% | 25,000 | +100.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 12,500 | 0.0% | 0.00% | – |
| Q3 2022 | $54,000 | -8.5% | 12,500 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -7.8% | 12,500 | 0.0% | 0.00% | – |
| Q1 2022 | $64,000 | -14.7% | 12,500 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $75,000 | -27.9% | 12,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $104,000 | -26.8% | 12,500 | -20.5% | 0.00% | 0.0% |
| Q2 2021 | $142,000 | -24.9% | 15,733 | -2.6% | 0.00% | 0.0% |
| Q1 2021 | $189,000 | -23.8% | 16,161 | -2.4% | 0.00% | -50.0% |
| Q4 2020 | $248,000 | +37.8% | 16,558 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $180,000 | -2.2% | 16,558 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $184,000 | +33.3% | 16,558 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $138,000 | +19.0% | 16,558 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $116,000 | -17.1% | 16,148 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $140,000 | -25.5% | 16,148 | +1.5% | 0.00% | -50.0% |
| Q2 2019 | $188,000 | -5.1% | 15,904 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $198,000 | +11.9% | 15,904 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $177,000 | -17.3% | 15,904 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $214,000 | -11.2% | 15,938 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $241,000 | -18.6% | 15,938 | +3.4% | 0.00% | 0.0% |
| Q1 2018 | $296,000 | -4.8% | 15,409 | -0.6% | 0.00% | 0.0% |
| Q4 2017 | $311,000 | +58.7% | 15,497 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $196,000 | +39.0% | 15,497 | +3.5% | 0.00% | 0.0% |
| Q2 2017 | $141,000 | +93.2% | 14,970 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $73,000 | +10.6% | 14,970 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $66,000 | +22.2% | 14,970 | +19.2% | 0.00% | – |
| Q3 2016 | $54,000 | -12.9% | 12,558 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $62,000 | -27.9% | 12,558 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $86,000 | -7.5% | 12,558 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $93,000 | +29.2% | 12,558 | -2.1% | 0.00% | 0.0% |
| Q3 2015 | $72,000 | -74.8% | 12,829 | -50.0% | 0.00% | 0.0% |
| Q2 2015 | $286,000 | +42.3% | 25,658 | +100.0% | 0.00% | -50.0% |
| Q1 2015 | $201,000 | -48.7% | 12,829 | -50.2% | 0.00% | 0.0% |
| Q4 2014 | $392,000 | +182.0% | 25,738 | +100.0% | 0.00% | +100.0% |
| Q3 2014 | $139,000 | -34.1% | 12,869 | -6.6% | 0.00% | -50.0% |
| Q2 2014 | $211,000 | -35.7% | 13,778 | -23.9% | 0.00% | -33.3% |
| Q1 2014 | $328,000 | +29.6% | 18,115 | -0.4% | 0.00% | +50.0% |
| Q4 2013 | $253,000 | -19.4% | 18,188 | -39.3% | 0.00% | 0.0% |
| Q3 2013 | $314,000 | +34.2% | 29,944 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $234,000 | – | 29,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |